Daily Cardiology Research Analysis
Three impactful cardiology studies stood out today: a multicenter Circulation study validated a new echocardiography algorithm that sharply reduces indeterminate left ventricular filling pressure and improves diagnostic accuracy against catheterization. A nationwide registry in European Journal of Cardio-Thoracic Surgery found mechanical aortic valves yield better survival and fewer reoperations than bioprostheses in adults aged 50–65. A meta-analysis in Circulation: Cardiovascular Imaging suppo
Summary
Three impactful cardiology studies stood out today: a multicenter Circulation study validated a new echocardiography algorithm that sharply reduces indeterminate left ventricular filling pressure and improves diagnostic accuracy against catheterization. A nationwide registry in European Journal of Cardio-Thoracic Surgery found mechanical aortic valves yield better survival and fewer reoperations than bioprostheses in adults aged 50–65. A meta-analysis in Circulation: Cardiovascular Imaging supports cardiac CT angiography as a viable alternative to TEE for post–left atrial appendage closure surveillance.
Research Themes
- Echo-based hemodynamic assessment and diastology
- Prosthesis selection in surgical aortic valve replacement (mechanical vs bioprosthetic)
- Imaging surveillance after left atrial appendage closure (CCTA vs TEE)
Selected Articles
1. New Algorithm for Estimating Left Ventricular Filling Pressure by Echocardiography.
In 951 catheterization-referred patients, a stepwise echocardiographic algorithm incorporating annular velocities, E/e′, PASP, and secondary LA parameters reduced indeterminate LV filling pressure classifications from 38 (2016 approach) to 2 while maintaining strong diagnostic accuracy for LVFP >15 mm Hg. Natriuretic peptides provided incremental value.
Impact: This provides a practical, validated pathway to estimate LV filling pressure with fewer indeterminate cases and better alignment with invasive standards.
Clinical Implications: Echo labs can adopt the stepwise algorithm to improve diagnostic certainty in dyspnea evaluation and diastology, potentially reducing unnecessary invasive studies and standardizing LVFP assessment.
Key Findings
- In a 951-patient multicenter cohort, the new stepwise algorithm reduced indeterminate LVFP from 38 (2016 guidelines) to 2 cases.
- The algorithm showed good accuracy for detecting elevated LVFP (>15 mm Hg) against the catheterization reference.
- Adding natriuretic peptide data provided incremental diagnostic value beyond echocardiographic parameters.
Methodological Strengths
- Gold-standard validation against invasive catheterization across multiple centers.
- Comprehensive echocardiographic profiling including LA strain with a prespecified stepwise decision algorithm.
Limitations
- Observational design with potential spectrum bias as only catheterization-referred patients were included.
- External validation beyond participating centers and prospective clinical impact assessment were not reported.
Future Directions: External, prospective validation across diverse populations; integration into reporting workflows and decision support; assess impact on downstream testing and outcomes.
BACKGROUND: Evaluation of whether dyspnea has a cardiac cause is essential. Guidelines from 2016 were reported to result in a high incidence of indeterminate left ventricular (LV) filling pressure. We sought to validate a new algorithm for the estimation of LV filling pressure (LVFP) in a multicenter study, with the objective of decreasing the yield of indeterminate filling pressure and increasing accuracy. METHODS: In an observational study, echocardiography was performed in 951 patients referred for cardiac catheterization. Echocardiographic measurements included mitral inflow, pulmonary vein and tissue Doppler mitral annulus velocities, tricuspid regurgitation velocity, assessment of mean right atrial pressure, biplane LV and left atrial volumes, and LV and left atrial strain. A stepwise approach was applied in a new algorithm for estimation of LVFP, whereby pressure >15 mm Hg was considered abnormally elevated. The first step included mitral annulus early diastolic velocity (e'), the ratio of mitral early flow velocity to e', and pulmonary artery systolic pressure. With concordant findings in all 3 variables, conclusions about LVFP could be reached. In case of discordant or incomplete variables, left atrial reservoir strain, left atrial maximum volume index, isovolumic relaxation time, and pulmonary vein flow were analyzed in a second step. In the presence of ≥1 abnormal measurement in the second step, the conclusion of elevated LVFP could be reached. RESULTS: Only 2 patients had indeterminate LVFP as per the new algorithm versus 38 applying 2016 guidelines ( CONCLUSIONS: The new algorithm increases the feasibility of estimating LVFP and has good accuracy with incremental value when natriuretic peptides are considered.
2. The choice of surgical aortic valve replacement type and mid-term outcomes in 50 to 65-year-olds: results of the AUTHEARTVISIT study.
In a nationwide Austrian cohort of 3,761 SAVR patients aged 50–65, mechanical valves were associated with lower all-cause mortality, fewer MACE, and lower reoperation risk than bioprostheses, with similar stroke and bleeding rates. Findings persisted after propensity matching.
Impact: These data directly inform valve choice in a common age range where practice has trended toward bioprostheses, highlighting potential survival disadvantages.
Clinical Implications: For 50–65-year-olds undergoing SAVR, clinicians should re-discuss mechanical valves as default options given survival and reoperation advantages, balancing anticoagulation needs with patient preferences.
Key Findings
- Mechanical valves were associated with lower all-cause mortality than bioprostheses (bioprosthesis vs mechanical HR 1.352; P=0.003).
- Bioprosthesis recipients had higher MACE (HR 1.182; P=0.03) and reoperation risk (HR 2.338; P=0.002).
- Stroke and bleeding risks were similar between groups; results persisted after propensity score matching.
Methodological Strengths
- Nationwide cohort with robust sample and hard clinical endpoints.
- Use of Cox/competing risk models and propensity score matching to reduce confounding.
Limitations
- Observational design with residual confounding and selection bias cannot be excluded.
- Granular data on anticoagulation adherence, valve hemodynamics, and patient preference were not detailed.
Future Directions: Develop shared decision-making tools integrating survival and reoperation trade-offs; pragmatic prospective registries stratified by anticoagulation management and lifestyle to refine selection.
OBJECTIVES: In recent years, the use of biological prosthetic valves has increased in patients under 65 years of age. This study evaluated overall survival, major adverse cardiac events and reoperation risk following surgical aortic valve replacement using either mechanical or biological prostheses in patients aged 50 to 65 years, aiming to provide data to support optimal valve selection in this group. METHODS: A registry-based cohort study was conducted using nationwide Austrian health insurance data from 1 January 2010 to 31 December 2020. Patients undergoing isolated surgical aortic valve replacement were classified based on valve type into mechanical or biological groups. The primary outcome was all-cause mortality. Secondary outcomes included major adverse cardiac events, reoperation, stroke, bleeding and survival after reoperation. Outcomes were assessed using Cox or competing risk regression models. Propensity score matching was used to reduce baseline differences. RESULTS: In the study cohort, 1018 patients were categorized to the mechanical and 2743 to the biological group. Patients who received mechanical valves had a significantly lower risk of death compared to those with biological valves (hazard ratio 1.352; P = 0.003). The biological group also had higher risks of major adverse cardiac events (hazard ratio 1.182; P = 0.03) and reoperation (hazard ratio 2.338; P = 0.002). Stroke and bleeding risks were similar between groups. All findings remained significant after propensity score matching. CONCLUSIONS: Among patients aged 50 to 65 years undergoing surgical aortic valve replacement, mechanical valves were associated with improved long-term survival, fewer major adverse events, and a lower need for repeat surgery. These findings suggest a need to re-evaluate the increasing use of biological valves in this age group.
3. Cardiac CT Versus Transesophageal Echocardiography Following Left Atrial Appendage Closure: A Systematic Review and Meta-Analysis.
Across 17 cohorts (1,313 patients) undergoing both modalities after LAAC, CCTA detected more residual leaks and any PDL than TEE, while detection of large PDL (>5 mm) and device-related thrombus was similar. This supports CCTA as an acceptable surveillance alternative, although the significance of patency without visible PDL remains unclear.
Impact: Directly informs imaging surveillance strategies after LAAC, supporting a noninvasive, widely available modality without compromising detection of clinically significant findings.
Clinical Implications: Centers may preferentially use CCTA for routine post-LAAC surveillance where feasible, reserving TEE for equivocal cases, suspected DRT, or when CT is contraindicated; protocols should address radiation/contrast exposure.
Key Findings
- CCTA detected residual leak (left atrial appendage patency) more often than TEE (58.8% vs 34.6%; OR 2.26; 95% CI 1.48–3.44).
- No significant differences between CCTA and TEE for detection of large PDL (>5 mm) and device-related thrombus.
- Meta-analysis encompassed 17 cohorts (n=1,313) with within-patient comparisons, and was preregistered on PROSPERO.
Methodological Strengths
- Systematic review and meta-analysis with preregistration and multi-database search.
- Within-patient comparisons across cohorts enhance internal validity of modality comparisons.
Limitations
- Included studies were observational with potential heterogeneity in acquisition protocols and timing.
- Clinical significance of LAA patency without visible PDL is uncertain and outcome linkage was limited.
Future Directions: Prospective head-to-head studies linking imaging findings (including patency without PDL) to thromboembolic outcomes; cost-effectiveness and patient-experience analyses for CT-first strategies.
BACKGROUND: In the landmark WATCHMAN trials, transesophageal echocardiography (TEE) was used to evaluate peri-device leak (PDL) and device-related thrombus (DRT) after percutaneous left atrial appendage closure (LAAC). We aimed to investigate the diagnostic utility of cardiac computed tomography angiography (CCTA) compared with TEE for post-LAAC device surveillance. METHODS: We conducted a literature search of 5 electronic databases to identify studies that included patients who underwent both CCTA and TEE after LAAC. We performed a meta-analysis by pooling outcomes for residual leak (left atrial appendage patency), any PDL, large PDL (>5 mm), and DRT. RESULTS: We included 17 cohort studies with 1313 patients who underwent both CCTA and TEE after LAAC. CCTA was associated with higher odds of detecting residual leak (58.8% versus 34.6%, odds ratio, 2.26 [95% CI, 1.48-3.44], CONCLUSIONS: Following LAAC, CCTA had higher odds of detecting residual leak and any PDL compared with TEE, whereas there were no significant differences in the detection of large PDL (> 5mm) and DRT between the 2 modalities. The findings of this meta-analysis should provide reassurance to patients and clinicians who prefer CCTA over TEE after LAAC. While DRT and left atrial appendage patency with visible PDL are known to be associated with thromboembolism, the clinical significance of left atrial appendage patency without visible PDL is uncertain and warrants further investigation. REGISTRATION: URL: https://www.crd.york.ac.uk/PROSPERO/; Unique identifier: CRD42024578802.